Aggregated forms of the amyloid-b peptide are hypothesized to act as the prime toxic agents in Alzheimer disease (AD). The in vivo amyloid-b peptide pool consists of both C-and N-terminally truncated or mutated peptides, and the composition thereof significantly determines AD risk. Other variations, such as biotinylation, are introduced as molecular tools to aid the understanding of disease mechanisms. Since these modifications have the potential to alter key aggregation properties of the amyloid-b peptide, we present a comparative study of the aggregation of a substantial set of the most common in vivo identified and in vitro produced amyloid-b peptides.
Introduction
Early aggregated forms of the amyloid-b peptide (Ab), which is generated from the amyloid precursor protein (APP), have been considered the basis for development of Alzheimer's disease (AD) [1, 2] . Despite extensive research, the exact link between Ab and AD remains elusive. One of the underlying reasons is that APP processing in vivo does not generate a single, well-defined species. The main cause for peptide heterogeneity stems from the identification of two main APP processing pathways, termed 'non-amyloidogenic' and 'amyloidogenic'. The non-amyloidogenic pathway involves APP cleavage by a-and c-secretase and generates the p3 peptide, an N-terminally truncated form of Ab, while the amyloidogenic pathway releases Ab by action of b-and c-secretase [3] . Besides the dual processing of APP generating either p3 or Ab, the c-secretase cleavage site is ill-defined resulting in variation at the C-terminus of Ab [4, 5] . As a result thereof, released Ab peptides vary in length from 27 to 49 amino acids [6, 7] . Additional variation in the in vivo Ab pool is attained by mutations within the Ab domain of APP. Known mutations inducing familial AD (FAD) include the Flemish (Ala21 to Gly), Dutch (Glu22 to Gln), Italian (Glu22 to Lys), Arctic (Glu22 to Gly), Iowa (Asp23 to Asn), and Tottori (Asp7 to Asn) mutations (reviewed by [8] ). An additional source of peptide variation results from the introduction of biotinylation as a research tool for interaction studies [9] [10] [11] [12] . All modifications described above could affect peptide behavior due to altered aggregation properties. In this study we systematically compared the aggregation behavior of p3 and Ab peptides resulting from heterogeneous APP processing as well as a selection of FAD-associated Ab mutants and biotinylated variants.
Materials and methods

Ab peptide synthesis
Ab and p3 peptides were produced by JPT (JPT Peptide Technologies, Germany). Details on peptide synthesis and analysis of peptide identity and purity are described in SI.
Solubilization of Ab peptides
Peptides were dissolved according to the standard procedure developed and validated in our laboratory [13] . In short, Ab peptides were dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). HFIP was evaporated using nitrogen gas and the peptide film was redissolved using dimethyl sulfoxide (DMSO). The peptide was separated from DMSO by elution from a HiTrap TM desalting column (GE Healthcare, cat. # 17-1408-01) into a 50 mM Tris pH 7.5 buffer containing 1 mM disodium ethylene-diaminetetraacetate (EDTA). The resulting samples were kept on ice until experiments started with a maximum lag time of 30 min. Peptide concentration was determined using the Coomassie (Bradford)
Protein Assay kit and diluted to 25 lM in 50 mM Tris pH 7.5 buffer containing 1 mM EDTA. Incubation of Ab peptides occurred for the given time periods at 25°C under quiescent conditions. This procedure was slightly adapted for the ATR-FTIR samples and is described in SI.
Thioflavin T fluorescence
Ab concentrations were adjusted to 1 lM using 50 mM Tris pH 7.5 buffer containing 1 mM EDTA and a final concentration of 12 lM Thioflavin T (ThT). The fibrillation kinetics of the various Ab preparations were monitored in situ in a Greiner 96-well plate using a FLUOstar OPTIMA fluorescence plate reader (BMG LABTECH GmbH, Germany) at an excitation wavelength of 440 nm and an emission wavelength of 480 nm. Fluorescence readings were recorded every 5 min for a period of 20 h. Measurements were performed as independent triplicates. Recorded values were averaged and background measurements (buffer containing 12 lM ThT) were subtracted.
Transmission electron microscopy
After 2 weeks of incubation, Ab aliquots (5 lL) were adsorbed to carbon-coated Formvar 400-mesh copper grids (Agar Scientific, cat. # S162-4) for 1 min. The grids were blotted, washed, and stained with 1% (wt/vol) uranyl acetate. Samples were studied with a JEOL JEM-1400 microscope (JEOL Ltd., Tokyo, Japan) at 80 kV. Images were collected from three independently prepared Ab solutions.
Dotblot
After 0.5 h of incubation a volume of 5 lL Ab was spotted onto a nitrocellulose membrane. The membranes were blocked in phosphate buffered saline containing 0.2% Tween-20 (1 h, 25°C), and incubated (1 h, 25°C) with primary A11 antibody (Invitrogen, cat. # AHB0052), diluted 1:4000 in 100 mM Hepes, pH 7.0 [14] . After incubation (0.5 h, 25°C) with a secondary anti-rabbit-HRP-tagged antibody (Promega, cat. # W4011), diluted 1:5000 in phosphate buffered saline containing 0.05% Tween-20, the membranes were visualized using the Immobilon TM Western chemiluminescent HRP substrate system. Spots were manually selected and intensities of the spots were analyzed as mean grey values using ImageJ software [15] . Images were background subtracted.
Attenuated total reflectance-Fourier-transform infrared spectroscopy
ATR-FTIR spectra were recorded on an Equinox 55 IR spectrophotometer (Bruker Optics, Ettlingen, Germany). Two micrograms of Ab was spread on the diamond surface (2 Â 2 mm 2 ) of the internal reflection element (ERI) and was washed with excess milliQ water to eliminate salts. Excess water was evaporated under nitrogen flow. Each spectrum represents the mean of 128 repetitions, recorded at a resolution of 2 cm À1 . Details on data processing are described in SI.
Statistical Analysis
The intensities of A11-positive spots as determined with ImageJ software were further analyzed using the two-tailed unpaired t-test for significance. Significant differences are denoted ⁄ P < 0.05.
Results
We present a comparison of the aggregation profiles of an extensive set of Ab peptides with N-or C-terminal variation, FAD-related mutations, and biotinylated forms of Ab. Ab peptides were prepared by peptide synthesis. Identity and purity were confirmed by MALDI-TOF MS and LC-MS ( Fig. S1-S4 ).
C-terminal elongation increases aggregation propensity and induces an amorphous fibrillar state
Aggregation kinetics of various Ab lengths were recorded by ThT fluorescence and two different aggregation profiles could be distinguished: slow aggregation accompanied with long nucleation times and high final fluorescence intensity were detected for Ab 1-37 , Ab 1-38 and Ab 1-40 , while Ab 1-42 and Ab 1-43 aggregated rapidly with almost immediate onset resulting in low final fluorescence intensity (Fig. 1A,B) . Fibril morphology has been related to different affinities for ThT binding affecting the extent of ThT fluorescence intensity [16, 17] . Visualization of fibrils by TEM indeed revealed morphologically distinct aggregates, showing extended negatively-stained fibrils for Ab 1-37 , Ab 1-38 and Ab , and heavily intertwined networks for Ab and Ab (Fig. 1C) . Structural analysis by ATR-FTIR at early time points confirmed that these peptides adopted a b-sheet conformation, as seen by strong absorption at 1630 cm À1 (Fig. 1E) . Apart from affecting fibril properties, increasing peptide length also leads to a more pronounced oligomerization as detected through dotblotting with the oligomer-specific A11 antibody (Fig. 1D) . Ab 1-37 , Ab 1-38 and Ab showed less oligomer accumulation after 0.5 h of incubation than Ab 1-42 and Ab . Accordingly, ATR-FTIR spectra observed for pre-fibrillar Ab 1-42 and Ab 1-43 suggested higher b-sheet content compared to oligomers produced from shorter Ab peptides which appeared more as a mixture of b-sheet, random coil and a-helical secondary structure elements (Table 1) . This confirms the earlier report that the conversion of monomeric Ab peptide into oligomers and mature fibrils coincides with the accumulation of a b-sheet enriched conformation [18] . The shorter Ab 1-37 , Ab 1-38 and Ab 1-40 displayed a higher b-sheet index [calculated as the ratio of the (1695/1630 cm À1 ) intensities] than the longer Ab 1-42 and Ab . This suggests a higher content of antiparallel b-strands which reflects a less extended conversion from the oligomeric, antiparallel conformation into the fibrillar, parallel conformation after 1.5 h of incubation [19] .
FAD mutations affect the aggregation rate to various extents but have little effect on fibril morphology and secondary structure
Familial mutations of Ab 1-42 displayed a short nucleation phase similar to that observed for wild type Ab 1-42 , but affected the rate of fibril elongation and final ThT fluorescence intensity ( Fig. 2A,B) . The slow polymerization of the D23N mutation coincided with a very low final ThT fluorescence, while A21G and E22Q mutations of Ab 1-42 aggregated at a higher rate with an increased final ThT fluorescence intensity compared to wild type Ab . All mutants of Ab 1-42 displayed a b-sheet enriched conformation (Fig. 2E , Table 1 ) and eventually formed similar dense fibrillar networks (Fig. 2C) . Oligomerization of the mutated Ab 1-42 peptides showed little variability as seen by A11-reactivity (Fig. 2D) , with exception of D23N Ab , and b-sheet index analysis indicated similar oligomer-content for the various peptides (Table 1) . and Ab N-and C-terminal biotinylation of Ab 1-40 increased the lag time of aggregation (Fig. 3A) while decreasing final ThT fluorescence (Fig. 3A,B) , indicative of inhibited aggregation, without affecting fibril morphology (Fig. 3C) . Oligomerization of biotinylated Ab 1-40, as probed by A11-reactivity, was unaffected (Fig. 3D) . Structural analysis of the peptides by ATR-FTIR however revealed absorption differences in the 1680-1640 cm À1 region (Fig. 3E , Table 1 ). Biotinylation of Ab 1-42 reduced polymerization of the peptide compared to wild type Ab (Fig. 3A) without significantly affecting final ThT fluorescence (Fig. 3B) , fibril morphology (Fig. 3C ) or secondary structure content (Fig. 3E, Table 1 ). For Ab 1-42 the impact of biotinylation on oligomerization depended on the location of the modification. C-terminal biotinylation did not affect A11-reactivity (Fig. 3D ) but resulted in a reduced b-sheet index (Table 1) . N-terminal modification on the other hand strongly impaired A11-reactivity (Fig. 3D ) but did not influence the b-sheet index ( Table 1) . The b-sheet index of biotinylated peptides however needs to be interpreted with caution as the biotin tag might absorb around 1695 cm À1 leading to an overestimation of this value.
Biotinylation affects aggregation of Ab
N-terminal truncation of Ab induces rapid onset aggregation
Both N-terminally truncated forms of Ab 1-40 and Ab 1-42 , p3 17-40 and p3 respectively, were characterized by rapid onset of aggregation compared to their corresponding full-length forms with decreased final ThT fluorescence intensity (Fig. 4A,B) . From a morphological perspective, visualization by TEM revealed short fibrillar fragments for p3 dissimilar from the long extended networks observed for full-length Ab (Fig. 4C) . Truncation of Ab 1-42 to p3 only slightly affected fibril morphology resulting in less curly fibrils (Fig. 4C) . Structural analysis by ATR-FTIR indicated that p3 17-40 displayed less b-sheets and more random coil and a-helical content than full-length Ab . A similar observation was made for p3 compared to Ab (Fig. 3E, Table 1 ). Oligomerization of the truncated p3 peptides, as analyzed by A11-reactivity and the b-sheet index, was not significantly affected compared to the full-length counterparts (Fig. 4D, Table 1 ).
Discussion
The in vivo Ab pool contains a high degree of variability, consisting of peptides with C-terminal variations, FAD-related mutations, and N-terminal truncations. To elucidate the mechanisms leading to Alzheimer disease (AD) some peptides have been additionally modified, e.g. biotinylated, to enable their investigation in experimental research. We chemically synthesized Ab peptide variants to compare their aggregation and oligomerization behaviors using biophysical techniques. Our observations show that variations in the Ab sequence can have consequences for the propensity of the Ab peptide to aggregate and oligomerize. C-terminal variation was previously shown to affect aggregation propensity, and it has been generally reported that Ab aggregates at a higher rate than Ab 1-40 [20, 21] . Even though approximately 90% of the Ab peptide pool is composed of these two peptides, it was recently recognized that also Ab 1-37 , Ab , and Ab are present in the brain and may modulate disease progress [22] . We show that C-terminal extension generally results in faster aggregation and gradual transformation into densely networked b-sheet rich aggregates compared to shorter peptides, which form extended fibrils characterized by a primarily disordered structure. We further observed that Ab 1-37 and Ab 1-38 generally behave similar to Ab 1-40 while the behavior of Ab 1-43 strongly resembles that of Ab . The dense fibril networks formed by Ab and Ab 1-43 possibly provide less access to the ThT dye compared to the more extended fibrils of shorter peptides, resulting in a lower final ThT fluorescence intensity. Alternatively, the denser peptide networks can be more prone to precipitation in the test tube which would lead to a similar observation. Although the effect of FAD-related mutations of Ab 1-42 on aggregation has been investigated in the past [23] [24] [25] [26] , no comprehensive study has been reported that directly compares the majority of the currently known mutations. Different Ab preparation methods and experimental conditions have led to considerable variation in reported effects of these mutations. ThT fluorescence data in this study were measured at a physiologically relevant Ab concentration of 1 lM.
Most FAD-related mutations are located in or near the central hydrophobic cluster of the Ab peptide, which has been predicted and reported to play an important role in aggregation [23, [27] [28] [29] [30] [31] . FAD mutations can thus either inhibit or induce aggregation depending on the suitability of the replacing amino acid to accommodate an amyloidogenic or aggregated structure. Molecular dynamics simulations have suggested the depletion of the E22-K28 salt bridge to explain the enhanced aggregation of E22Q Ab , while the switch of a bend motif to a turn in the region Ab [22] [23] [24] [25] [26] [27] [28] could result in slower aggregation of the D23N Ab 1-42 mutant [25] . Overall fibril morphology is however not affected, as has been shown previously for a subset of FAD mutants [23] . The central hydrophobic region is however not the absolute key in determining aggregation tendency as a subset of the FAD mutations in this region has no effect on the aggregation rate and most likely exert their pathological function through aberrant APP processing or reduced proteolytic Ab degradation [32] [33] [34] . We further show that C-terminal elongation, which does not affect the central region of Ab, also affects aggregation. Moreover, complete destruction of the central aggregation zone by deletion of the first 17 N-terminal amino acids, as naturally occurs by APP processing via the nonamyloidogenic pathway, does not abolish the aggregating character of the peptides, as was observed before [35] and upregulation of the a-secretase cleavage pathway initiating the non-amyloidogenic processing of APP has served as a template for the generation of various potential disease modulating drugs [36] . It is thus likely to suggest that, even though the central Ab region can play a regulating role in the aggregation process, the C-terminal region may dominate this effect by determining fibril morphology. Biotinylation of Ab has been applied in several studies [9] [10] [11] [12] . Our data show that this modification can affect the onset of aggregation substantially depending on the type of biotinylation applied and its location, either N-or C-terminally, without affecting fibril morphology or oligomer formation. These observations underline the importance of selecting and validating the type of labeling required for experiments without inducing changes in the peptide behavior that are subject to study.
In this work we systematically compared a wide range of Ab peptides for their aggregation properties. The overall aggregation profile was determined by thioflavin T fluorescence while we attempted to gain insight in early aggregation events by probing oligomerization of the peptides. We therefore used A11-reactivity as well as analysis of secondary structure content which were however not always completely in agreement. This could be attributed to the polyclonal nature of the A11 antibody [14] that can be hypothesized to recognize more than one conformation. On the other hand, it might be likely that both methods detect different oligomeric species. In conclusion, the results highlight that minor sequential variations may have consequences for the aggregation of Ab. 
